ANDA 40524, held by Bedford Labs. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40524 (Promethazine Hydrochloride), held by Bedford Labs, was first approved by FDA on Mar 17, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 17, 2004 | Original application | Approved | None posted |
| Promethazine Hydrochloride25MG/ML · injectable;injection | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride50MG/ML · injectable;injection | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters